These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17094673)

  • 1. [The cognitive effect of alprazolam in healthy volunteers].
    Drabant S; Tömlo J; Tóth M; Péterfai E; Klebovich I
    Acta Pharm Hung; 2006; 76(1):25-31. PubMed ID: 17094673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprazolam absorption kinetics affects abuse liability.
    Mumford GK; Evans SM; Fleishaker JC; Griffiths RR
    Clin Pharmacol Ther; 1995 Mar; 57(3):356-65. PubMed ID: 7697954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam.
    Snyder PJ; Werth J; Giordani B; Caveney AF; Feltner D; Maruff P
    Hum Psychopharmacol; 2005 Jun; 20(4):263-73. PubMed ID: 15912482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytics and memory: a comparison of lorazepam and alprazolam.
    Kumar R; Mac DS; Gabrielli WF; Goodwin DW
    J Clin Psychiatry; 1987 Apr; 48(4):158-60. PubMed ID: 3558328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
    Blin O; Micallef J; Audebert C; Legangneux E
    J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of alprazolam in humans.
    Kelly TH; Foltin RW; Serpick E; Fischman MW
    Behav Pharmacol; 1997 Feb; 8(1):47-57. PubMed ID: 9833000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
    Mumford GK; Rush CR; Griffiths RR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.
    Wesnes KA; Edgar C; Tretter RN; Bolodeoku J
    Expert Opin Drug Saf; 2009 Nov; 8(6):615-26. PubMed ID: 19747069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor.
    Rosenzweig P; Patat A; Zieleniuk I; Cimarosti I; Allain H; Gandon JM
    Clin Pharmacol Ther; 1998 Aug; 64(2):211-22. PubMed ID: 9728902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses.
    Danjou P; Warot D; Hergueta T; Lacomblez L; Bouhours P; Puech AJ
    Int Clin Psychopharmacol; 1992 Nov; 7(2):73-9. PubMed ID: 1487624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effects of clonidine and temazepam on attention and memory.
    Tiplady B; Bowness E; Stien L; Drummond G
    J Psychopharmacol; 2005 May; 19(3):259-65. PubMed ID: 15888511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alprazolam 0.125 mg twice a day improves aspects of psychometric performance in healthy volunteers.
    Bourin M; Colombel MC; Guitton B
    J Clin Psychopharmacol; 1998 Oct; 18(5):364-72. PubMed ID: 9790153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.
    Hindmarch I; Trick L; Ridout F
    Psychopharmacology (Berl); 2005 Dec; 183(2):133-43. PubMed ID: 16205916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
    Evans SM; Troisi JR; Griffiths RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the single-dose effects of alprazolam, buspirone, and placebo upon memory function.
    Barbee JG; Black FW; Kehoe CE; Todorov AA
    J Clin Psychopharmacol; 1991 Dec; 11(6):351-6. PubMed ID: 1770153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.